| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |